A detailed history of Barclays PLC transactions in Bio Techne Corp stock. As of the latest transaction made, Barclays PLC holds 332,098 shares of TECH stock, worth $24.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
332,098
Previous 332,098 -0.0%
Holding current value
$24.3 Million
Previous $26.5 Million -0.0%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$70.96 - $82.35 $1.03 Million - $1.19 Million
-14,504 Reduced 4.18%
332,098 $26.5 Million
Q2 2024

Aug 14, 2024

BUY
$62.12 - $84.15 $53,485 - $72,453
861 Added 0.25%
346,602 $24.8 Million
Q1 2024

May 15, 2024

SELL
$65.98 - $77.09 $2.68 Million - $3.13 Million
-40,649 Reduced 10.52%
345,741 $24.3 Million
Q4 2023

Feb 15, 2024

BUY
$52.83 - $78.22 $4.16 Million - $6.17 Million
78,835 Added 25.63%
386,390 $29.8 Million
Q3 2023

Nov 07, 2023

BUY
$67.52 - $89.42 $566,492 - $750,233
8,390 Added 2.8%
307,555 $20.9 Million
Q2 2023

Aug 03, 2023

BUY
$73.76 - $85.98 $11.9 Million - $13.9 Million
161,922 Added 117.98%
299,165 $24.4 Million
Q1 2023

May 04, 2023

SELL
$71.62 - $86.62 $4.32 Million - $5.22 Million
-60,285 Reduced 30.52%
137,243 $10.2 Million
Q4 2022

Feb 13, 2023

BUY
$80.67 - $352.29 $12.7 Million - $55.6 Million
157,815 Added 397.39%
197,528 $16.4 Million
Q3 2022

Nov 03, 2022

BUY
$282.54 - $391.85 $3.15 Million - $4.37 Million
11,147 Added 39.02%
39,713 $11.3 Million
Q2 2022

Aug 12, 2022

SELL
$322.67 - $449.65 $6.6 Million - $9.19 Million
-20,449 Reduced 41.72%
28,566 $9.9 Million
Q1 2022

May 16, 2022

SELL
$353.85 - $487.79 $6.3 Million - $8.68 Million
-17,800 Reduced 26.64%
49,015 $21.2 Million
Q4 2021

Feb 14, 2022

BUY
$456.15 - $525.06 $1.94 Million - $2.23 Million
4,254 Added 6.8%
66,815 $34.6 Million
Q3 2021

Nov 09, 2021

BUY
$444.87 - $538.88 $5.8 Million - $7.03 Million
13,046 Added 26.35%
62,561 $30.3 Million
Q2 2021

Aug 13, 2021

BUY
$387.35 - $450.26 $17.4 Million - $20.2 Million
44,959 Added 986.81%
49,515 $22.3 Million
Q1 2021

May 13, 2021

BUY
$314.62 - $411.0 $704,434 - $920,229
2,239 Added 96.63%
4,556 $1.74 Million
Q4 2020

Feb 11, 2021

BUY
$246.9 - $321.87 $266,898 - $347,941
1,081 Added 87.46%
2,317 $736,000
Q3 2020

Nov 12, 2020

SELL
$232.22 - $282.96 $594,947 - $724,943
-2,562 Reduced 67.46%
1,236 $306,000
Q2 2020

Aug 12, 2020

SELL
$185.43 - $279.56 $3.59 Million - $5.41 Million
-19,365 Reduced 83.6%
3,798 $1 Million
Q1 2020

May 13, 2020

BUY
$161.17 - $221.51 $1.84 Million - $2.53 Million
11,405 Added 97.0%
23,163 $4.39 Million
Q4 2019

Feb 10, 2020

BUY
$189.68 - $222.09 $1.76 Million - $2.06 Million
9,284 Added 375.26%
11,758 $2.58 Million
Q3 2019

Nov 14, 2019

SELL
$183.56 - $216.72 $2.02 Million - $2.39 Million
-11,021 Reduced 81.67%
2,474 $485,000
Q2 2019

Aug 14, 2019

BUY
$188.72 - $215.43 $1.14 Million - $1.31 Million
6,067 Added 81.68%
13,495 $2.81 Million
Q1 2019

May 15, 2019

SELL
$136.09 - $200.44 $1.64 Million - $2.42 Million
-12,080 Reduced 61.92%
7,428 $1.48 Million
Q4 2018

Feb 14, 2019

BUY
$132.75 - $203.8 $649,280 - $996,785
4,891 Added 33.46%
19,508 $2.82 Million
Q3 2018

Nov 14, 2018

SELL
$147.44 - $204.11 $4.57 Million - $6.33 Million
-30,999 Reduced 67.96%
14,617 $2.98 Million
Q2 2018

Aug 14, 2018

BUY
$144.9 - $165.58 $3.39 Million - $3.87 Million
23,381 Added 105.15%
45,616 $6.75 Million
Q1 2018

May 15, 2018

SELL
$131.46 - $151.04 $940,596 - $1.08 Million
-7,155 Reduced 24.35%
22,235 $3.36 Million
Q4 2017

Feb 14, 2018

BUY
$121.17 - $134.75 $15,146 - $16,843
125 Added 0.43%
29,390 $3.81 Million
Q3 2017

Nov 14, 2017

BUY
$113.59 - $123.78 $3.32 Million - $3.62 Million
29,265
29,265 $3.54 Million

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.86B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.